SINGULAIR (montelukast) – a leukotriene receptor antagonist commonly used to treat asthma, bronchoconstriction and certain allergic conditions. Leukotrienes have been correlated with the pathophysiology of asthma and allergic rhinitis. Montelukast inhibits physiologic actions of leukotrienes on airways, bronchial smooth muscle, and cells associated with the inflammatory process in asthma or the allergic process in allergic […]
SPIRIVA (tiotropium bromide) – an anticholinergic inhaled product commonly used to treat bronchospasm in patients with chronic obstructive pulmonary disease. FDA approved uses: Spiriva is indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), and for reducing COPD exacerbations. Available dosage forms: Capsules for oral inhalation. 18 mcg […]
ADVAIR (fluticasone/salmererol) – an inhaled combination product containing a corticosteroid (fluticasone), and a long-acting beta-2 adrenergic agonist (salmeterol) commonly used to treat asthma and chronic obstructive pulmonary disease (COPD). The mechanism of action for fluticasone/salmererol is related to the two active ingredients. Fluticasone is a potent corticosteroid that posses anti-inflammatory properties, relieving inflammation in the […]